Ptc Therapeutics (PTCT) Change in Acquisitions & Divestments (2016 - 2025)
Ptc Therapeutics (PTCT) has 13 years of Change in Acquisitions & Divestments data on record, last reported at -$365.5 million in Q4 2025.
- For Q4 2025, Change in Acquisitions & Divestments fell 5721.14% year-over-year to -$365.5 million; the TTM value through Dec 2025 reached $58.8 million, up 22.19%, while the annual FY2025 figure was $58.8 million, 22.19% up from the prior year.
- Change in Acquisitions & Divestments reached -$365.5 million in Q4 2025 per PTCT's latest filing, down from $177.2 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $392.1 million in Q1 2021 and bottomed at -$689.0 million in Q4 2021.
- Average Change in Acquisitions & Divestments over 5 years is $12.3 million, with a median of $9.2 million recorded in 2023.
- Peak YoY movement for Change in Acquisitions & Divestments: soared 2707.38% in 2024, then plummeted 5721.14% in 2025.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at -$689.0 million in 2021, then soared by 101.24% to $8.5 million in 2022, then rose by 11.01% to $9.5 million in 2023, then tumbled by 31.3% to $6.5 million in 2024, then tumbled by 5721.14% to -$365.5 million in 2025.
- Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were -$365.5 million in Q4 2025, $177.2 million in Q3 2025, and $238.3 million in Q2 2025.